138 related articles for article (PubMed ID: 28159518)
1. Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine.
Markovsky E; Eldar-Boock A; Ben-Shushan D; Baabur-Cohen H; Yeini E; Pisarevsky E; Many A; Aviel-Ronen S; Barshack I; Satchi-Fainaro R
J Control Release; 2017 Mar; 249():162-172. PubMed ID: 28159518
[TBL] [Abstract][Full Text] [Related]
2. PEGylated dendritic polyglycerol conjugate targeting NCAM-expressing neuroblastoma: Limitations and challenges.
Vossen LI; Markovsky E; Eldar-Boock A; Tschiche HR; Wedepohl S; Pisarevsky E; Satchi-Fainaro R; Calderón M
Nanomedicine; 2018 Jun; 14(4):1169-1179. PubMed ID: 29471169
[TBL] [Abstract][Full Text] [Related]
3. Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel.
Eldar-Boock A; Miller K; Sanchis J; Lupu R; Vicent MJ; Satchi-Fainaro R
Biomaterials; 2011 May; 32(15):3862-74. PubMed ID: 21376390
[TBL] [Abstract][Full Text] [Related]
4. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs.
Markovsky E; Baabur-Cohen H; Satchi-Fainaro R
J Control Release; 2014 Aug; 187():145-57. PubMed ID: 24862318
[TBL] [Abstract][Full Text] [Related]
5. Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine.
Markovsky E; Vax E; Ben-Shushan D; Eldar-Boock A; Shukrun R; Yeini E; Barshack I; Caspi R; Harari-Steinberg O; Pode-Shakked N; Dekel B; Satchi-Fainaro R
Mol Cancer Ther; 2017 Nov; 16(11):2462-2472. PubMed ID: 28729402
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and biological evaluation of poly(L-γ-glutamyl-glutamine)- paclitaxel nanoconjugate.
Van S; Das SK; Wang X; Feng Z; Jin Y; Hou Z; Chen F; Pham A; Jiang N; Howell SB; Yu L
Int J Nanomedicine; 2010 Oct; 5():825-37. PubMed ID: 21042550
[TBL] [Abstract][Full Text] [Related]
7. Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study.
Eldar-Boock A; Blau R; Ryppa C; Baabur-Cohen H; Many A; Vicent MJ; Kratz F; Sanchis J; Satchi-Fainaro R
J Drug Target; 2017; 25(9-10):829-844. PubMed ID: 28737432
[TBL] [Abstract][Full Text] [Related]
8. Expression of the neural cell adhesion molecule and polysialic acid in human neuroblastoma cell lines.
Valentiner U; Mühlenhoff M; Lehmann U; Hildebrandt H; Schumacher U
Int J Oncol; 2011 Aug; 39(2):417-24. PubMed ID: 21567084
[TBL] [Abstract][Full Text] [Related]
9. Polymer-drug conjugates: recent development in clinical oncology.
Li C; Wallace S
Adv Drug Deliv Rev; 2008 May; 60(8):886-98. PubMed ID: 18374448
[TBL] [Abstract][Full Text] [Related]
10. Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression.
Blaheta RA; Daher FH; Michaelis M; Hasenberg C; Weich EM; Jonas D; Kotchetkov R; Doerr HW; Cinatl J
BMC Cancer; 2006 Dec; 6():294. PubMed ID: 17181871
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases.
Shaffer SA; Baker-Lee C; Kennedy J; Lai MS; de Vries P; Buhler K; Singer JW
Cancer Chemother Pharmacol; 2007 Mar; 59(4):537-48. PubMed ID: 16924498
[TBL] [Abstract][Full Text] [Related]
12. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
[TBL] [Abstract][Full Text] [Related]
14. Expression level of neural cell adhesion molecule (NCAM) inversely correlates with the ability of neuroblastoma cells to adhere to endothelium in vitro.
Blaheta RA; Hundemer M; Mayer G; Vogel JU; Kornhuber B; Cinatl J; Markus BH; Driever PH; Cinatl J
Cell Commun Adhes; 2002; 9(3):131-47. PubMed ID: 12521134
[TBL] [Abstract][Full Text] [Related]
15. PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2.
Albain KS; Belani CP; Bonomi P; O'Byrne KJ; Schiller JH; Socinski M
Clin Lung Cancer; 2006 May; 7(6):417-9. PubMed ID: 16800969
[No Abstract] [Full Text] [Related]
16. Localization of 131I-labelled monoclonal antibody ERIC1 in a subcutaneous xenograft model of neuroblastoma in SCID mice.
Otto C; Jensen M; Dietlein M; Fischer T; Schmidt M; Tawadros S; Börner SM; Weber SA; Spitz R; Bloch W; Berthold F; Schicha H; Schomäcker K
Nucl Med Commun; 2006 Feb; 27(2):171-8. PubMed ID: 16404231
[TBL] [Abstract][Full Text] [Related]
17. Transferrin conjugated poly (γ-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery.
Zhao C; Liu X; Liu J; Yang Z; Rong X; Li M; Liang X; Wu Y
Colloids Surf B Biointerfaces; 2014 Nov; 123():787-96. PubMed ID: 25454663
[TBL] [Abstract][Full Text] [Related]
18. Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.
Langer CJ; O'Byrne KJ; Socinski MA; Mikhailov SM; Leśniewski-Kmak K; Smakal M; Ciuleanu TE; Orlov SV; Dediu M; Heigener D; Eisenfeld AJ; Sandalic L; Oldham FB; Singer JW; Ross HJ
J Thorac Oncol; 2008 Jun; 3(6):623-30. PubMed ID: 18520802
[TBL] [Abstract][Full Text] [Related]
19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
20. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.
Li C; Yu DF; Newman RA; Cabral F; Stephens LC; Hunter N; Milas L; Wallace S
Cancer Res; 1998 Jun; 58(11):2404-9. PubMed ID: 9622081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
